UAMY Thesis Assessment
United States Antimony Corporation
UAMY's market price of $9.11 appears to be above the fundamental value indicated by this analysis.
At approximately $1.13B market cap on $39.26M FY2025 revenue ($9.11 stock price implying ~29x revenue), the prediction ensemble's concerns are validated by FY2025 earnings. Revenue missed the $40M guidance floor by $740K, confirming the FRAGILE revenue durability classification. CEO explicitly acknowledged growth was 'price, not volume.' CAPITAL_DEPLOYMENT escalated to QUESTIONABLE (Thompson Falls 5 months late, $37.2M illiquid Larvotto stake, 71% capex-to-revenue ratio). EXPECTATIONS_PRICED escalated to EXTREMELY AGGRESSIVE ($125M FY2026 guidance requires 3.18x growth with no expansion-related Q1 revenue). Even after the 29% stock decline from $12.91, the valuation still embeds extraordinary execution assumptions with no historical precedent. At mining-norm P/S multiples of 2-3x, fair value on FY2025 revenue would be $0.80-1.20/share.
What the Markets Suggest
FY2025 earnings data confirms and strengthens the price-above-value thesis. The $39.26M revenue (+163% YoY) represents a genuine operational milestone from a $15M historical base, but the $740K miss below the $40M guidance floor validates the committee's directional concerns. CEO Evans' candid admission that 2025 growth was 'price, not volume' is the single most important disclosure -- it confirms the FRAGILE revenue durability classification with management's own words.
Four signal changes net to a reinforced HIGHER_SCRUTINY posture. Two improvements are genuine: FUNDING_FRAGILITY upgraded to STABLE ($91.3M cash, near-zero debt, 222 institutional holders including BlackRock and Vanguard) and REGULATORY_EXPOSURE upgraded to FAVORABLE ($248M DLA contract with first delivery imminent, tightening China export restrictions). Two escalations are concerning: CAPITAL_DEPLOYMENT worsened to QUESTIONABLE (Thompson Falls 5 months late, $37.2M illiquid Larvotto stake, 71% capex-to-revenue ratio, 8 concurrent projects across 6 jurisdictions from 145 employees) and EXPECTATIONS_PRICED escalated to EXTREMELY AGGRESSIVE ($125M guidance requires 3.18x growth, quarterly revenue at 2.2x the historical best for three consecutive quarters starting Q2 2026).
The cross-lens pattern is clear: the balance sheet transformation is real but dilution-funded (not earned from operations), the regulatory environment is enabling but the operational capability is the constraint, and the widening gap between narrative velocity ('warp speed') and execution velocity (5-month delays, two exploration failures, zero domestic mine production) is the defining characteristic of this situation.
Three markets resolved with an average Brier score of 0.259. The guidance maintenance prediction was strong (0.09), the Montana expansion delay prediction was moderate (0.303), and the revenue guidance hit prediction was weak (0.384 -- ensemble was too optimistic). The 29% stock decline from $12.91 to $9.11 reflects partial market recognition, but the remaining ~$1.13B market cap still prices in near-complete execution of guidance that the ensemble and now the earnings data suggest is physically constrained.
Market Contributions6 markets
Resolved NO -- FY2025 revenue of $39.26M missed the $40M floor by $740K. The ensemble assigned 62% probability to YES, producing a Brier score of 0.384 (weak). The marginal miss validates the committee's FRAGILE classification while exposing the ensemble's slight overconfidence in management guidance. CEO's admission that growth was 'price, not volume' confirms the revenue quality concern underlying this market.
Resolved YES -- management reiterated $125M FY2026 guidance backed by $354M contract backlog ($248M DLA + $106.7M industrial). Brier score of 0.09 (strong). The ensemble correctly predicted management behavior with the highest agreement (0.82). However, guidance maintenance is informative about management messaging, not business fundamentals -- the $125M target now requires 3.18x growth from a $39.26M base with no expansion-related Q1 revenue.
Resolved NO -- Thompson Falls delayed approximately 5 months from December 2025 to May 2026. Brier score of 0.303 (moderate). The ensemble's 55% YES probability was directionally ambivalent but leaned wrong. The delay validates the CAPITAL_DEPLOYMENT escalation to QUESTIONABLE and cascades through all revenue projections for the $125M guidance.
The most critical remaining execution test. At only 38% probability, the ensemble strongly doubts Q1 2026 revenue will be on pace for $125M annually. With management admitting no expansion-related Q1 revenue, the remaining three quarters must average ~$28.6M -- more than double the best quarter in company history ($13.06M implied Q4 2025). This market gains urgency after the FY2025 miss.
Near coin-flip at 52%. FY2025 confirmed the revenue thesis is overwhelmingly price-driven (CEO: 'the real growth was in price'). If antimony normalizes below $20/lb while the volume pivot remains unproven, revenue collapses from both directions. The China export restriction tightening is a tailwind but antimony pricing remains the exogenous variable with highest impact.
Competitive moat erosion timeline at 58% probability with lowest agreement (0.65). The window of US antimony exclusivity is now one year closer to closing. The CONDITIONAL competitive position requires Thompson Falls operational + own-mine ore before this window narrows.
Balancing Factors
Balance sheet transformed: $91.3M cash, near-zero debt ($195K), working capital expanded from $16.7M to $44.6M -- reduces existential risk and provides 12-20 months runway
DLA contract upgraded to $248M with first physical delivery imminent -- transitioning from contractual commitment to operational execution
China antimony export restrictions tightening (shipments 'cut off' since September 2024) -- strengthens sole US producer moat near-term
Institutional ownership doubled to 40% (222 holders including BlackRock, Vanguard, State Street) -- signals continued equity market access
New COO Melissa Pagen explicitly acknowledged 'temptation to pursue too many opportunities' -- first management voice naming execution risk
$354M contract backlog ($248M DLA + $106.7M industrial) provides revenue visibility if execution follows
Key Uncertainties
Whether the 2026 'volume pivot' materializes -- CEO promised volume-driven growth but this has never been demonstrated at any scale
Thompson Falls ramp curve post-May 2026 commissioning -- no production data or throughput timeline disclosed
Whether $91.3M cash buffer is sufficient for 8 concurrent projects or whether additional dilutive equity issuance will be required
The true margin profile of DLA deliveries vs. spot market sales -- delivery mechanics and payment terms remain opaque
Larvotto Resources exit strategy -- $37.2M illiquid position (10% of undeveloped Australian mine) with rejected takeover bid and no clear recovery path
Whether antimony prices are structurally elevated (permanent supply restriction) or cyclically inflated (temporary hoarding and speculation)
Balance sheet transformation ($91.3M cash, near-zero debt) reduces existential risk. DLA contract upgraded to $248M with first delivery imminent. Critical minerals policy tailwinds are bipartisan and structural. These genuine improvements buy time but do not resolve the fundamental execution gap between narrative and operational capability.
Confidence note: Confidence upgraded from MEDIUM to MEDIUM-HIGH based on FY2025 actuals confirming the ensemble's directional assessments. Three markets resolved: revenue guidance miss (NO, Brier 0.384 -- ensemble was too optimistic at 62%), guidance maintained (YES, Brier 0.09 -- strong call), Montana expansion delayed (NO, Brier 0.303 -- ensemble correctly leaned toward delay). Average Brier of 0.259 reflects mixed but informative calibration. The revenue miss, management's own 'price not volume' admission, and Thompson Falls delay collectively validate the DISCONNECTED narrative-reality gap with higher-evidence-tier data (E3).
This assessment synthesizes probabilistic forecasts from an AI model ensemble for educational and informational purposes only. Model outputs may contain errors, hallucinations, or data lag. It does not constitute financial advice, a recommendation to buy or sell securities, or a guarantee of future outcomes. Past model performance does not predict future accuracy. Investors should conduct their own research and consult qualified financial advisors before making investment decisions.